These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 30365550

  • 1. MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's disease.
    Bertoglio D, Verhaeghe J, Kosten L, Thomae D, Van der Linden A, Stroobants S, Wityak J, Dominguez C, Mrzljak L, Staelens S.
    PLoS One; 2018; 13(10):e0206613. PubMed ID: 30365550
    [Abstract] [Full Text] [Related]

  • 2. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS, Barret O, Jennings DL, Friedman JH, Tamagnan GD, Thomae D, Alagille D, Morley TJ, Papin C, Papapetropoulos S, Waterhouse RN, Seibyl JP, Marek KL.
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [Abstract] [Full Text] [Related]

  • 3. Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice.
    Ooms M, Rietjens R, Rangarajan JR, Vunckx K, Valdeolivas S, Maes F, Himmelreich U, Fernandez-Ruiz J, Bormans G, Van Laere K, Casteels C.
    Neurobiol Aging; 2014 Dec; 35(12):2858-2869. PubMed ID: 25018107
    [Abstract] [Full Text] [Related]

  • 4. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
    Barret O, Thomae D, Tavares A, Alagille D, Papin C, Waterhouse R, McCarthy T, Jennings D, Marek K, Russell D, Seibyl J, Tamagnan G.
    J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
    [Abstract] [Full Text] [Related]

  • 5. Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
    Russell DS, Jennings DL, Barret O, Tamagnan GD, Carroll VM, Caillé F, Alagille D, Morley TJ, Papin C, Seibyl JP, Marek KL.
    Neurology; 2016 Feb 23; 86(8):748-54. PubMed ID: 26802091
    [Abstract] [Full Text] [Related]

  • 6. Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.
    Wilson H, Niccolini F, Haider S, Marques TR, Pagano G, Coello C, Natesan S, Kapur S, Rabiner EA, Gunn RN, Tabrizi SJ, Politis M.
    J Neurol Sci; 2016 Sep 15; 368():243-8. PubMed ID: 27538642
    [Abstract] [Full Text] [Related]

  • 7. Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D1R Radioligand [11C]SCH23390 in Healthy and Diseased Mice.
    Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Dominguez C, Munoz-Sanjuan I, Skinbjerg M, Liu L, Staelens S.
    Mol Imaging Biol; 2021 Apr 15; 23(2):208-219. PubMed ID: 33179158
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Longitudinal Characterization of mGluR5 Using 11C-ABP688 PET Imaging in the Q175 Mouse Model of Huntington Disease.
    Bertoglio D, Kosten L, Verhaeghe J, Thomae D, Wyffels L, Stroobants S, Wityak J, Dominguez C, Mrzljak L, Staelens S.
    J Nucl Med; 2018 Nov 15; 59(11):1722-1727. PubMed ID: 29794227
    [Abstract] [Full Text] [Related]

  • 10. PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression.
    Fazio P, Fitzer-Attas CJ, Mrzljak L, Bronzova J, Nag S, Warner JH, Landwehrmeyer B, Al-Tawil N, Halldin C, Forsberg A, Ware J, Dilda V, Wood A, Sampaio C, Varrone A, PEARL-HD and LONGPDE10 study collaborators.
    Mov Disord; 2020 Apr 15; 35(4):606-615. PubMed ID: 31967355
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [(11)C]T-773.
    Tóth M, Häggkvist J, Stepanov V, Takano A, Nakao R, Amini N, Miura S, Kimura H, Taniguchi T, Gulyás B, Halldin C.
    Mol Imaging Biol; 2015 Aug 15; 17(4):445-9. PubMed ID: 25622810
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentation.
    Bagci U, Kramer-Marek G, Mollura DJ.
    EJNMMI Res; 2013 Jul 05; 3(1):49. PubMed ID: 23829944
    [Abstract] [Full Text] [Related]

  • 17. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K, Ahmad RU, Hudyana H, Dubois K, Schmidt ME, Celen S, Bormans G, Koole M.
    J Nucl Med; 2013 Aug 05; 54(8):1285-93. PubMed ID: 23843566
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
    Leuti A, Laurenti D, Giampà C, Montagna E, Dato C, Anzilotti S, Melone MA, Bernardi G, Fusco FR.
    Neurobiol Dis; 2013 Apr 05; 52():104-16. PubMed ID: 23220622
    [Abstract] [Full Text] [Related]

  • 20. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
    Hwang DR, Hu E, Allen JR, Davis C, Treanor J, Miller S, Chen H, Shi B, Narayanan TK, Barret O, Alagille D, Yu Z, Slifstein M.
    Nucl Med Biol; 2015 Aug 05; 42(8):654-63. PubMed ID: 25935386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.